---
created: 2025-04-13
updated: 2025-04-13T10:52
id: o/0k@V0YpS
specialty: pharmaco
specialty_id: 265
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::07-anticoagulants
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::06-thrombolytics
  - "source/ak-step1-v11:": 
  - theme/nbme::30
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::13-hematology-oncology::11-hemostasis
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::17-hem/onc-pharm::thrombolytics
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::10-heme::thrombolytics-(tpa,-streptokinase,-urokinase)
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::03-blood-&-inflammation::01-anticoagulants-&-thrombolytics::04-thrombolytics
  - source/ak-step1-v11::^other::^highyield::1-highyield"
type: flashcard
---

# Question
Thrombolytics (eg, alteplase tPA) exert their effects via direct or indirect conversion of plasminogen to **plasmin**

---

# Answer
